You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR SYMMETREL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for SYMMETREL

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00627250 ↗	Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability	Completed	U.S. Department of Education	N/A	2003-03-01	The purpose of this study is to determine if amantadine hydrochloride given 100 mg in the morning and at noon is safe and effective in the treatment of mood and behavior changes (i.e. irritability) after sustaining traumatic brain injury.
NCT00627250 ↗	Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability	Completed	Atrium Health	N/A	2003-03-01	The purpose of this study is to determine if amantadine hydrochloride given 100 mg in the morning and at noon is safe and effective in the treatment of mood and behavior changes (i.e. irritability) after sustaining traumatic brain injury.
NCT00627250 ↗	Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability	Completed	Carolinas Healthcare System	N/A	2003-03-01	The purpose of this study is to determine if amantadine hydrochloride given 100 mg in the morning and at noon is safe and effective in the treatment of mood and behavior changes (i.e. irritability) after sustaining traumatic brain injury.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for SYMMETREL

Condition Name

Chart
Table

Condition Name for SYMMETREL
Intervention	Trials
Traumatic Brain Injury	4
Aggression	2
Parkinson's Disease	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for SYMMETREL
Intervention	Trials
Brain Injuries	5
Brain Injuries, Traumatic	5
Wounds and Injuries	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for SYMMETREL

Trials by Country

Map
Table

Trials by Country for SYMMETREL
Location	Trials
United States	30
Austria	1
Israel	1
Germany	1
Canada	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for SYMMETREL
Location	Trials
North Carolina	4
Massachusetts	4
Illinois	4
Oregon	2
Florida	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for SYMMETREL

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for SYMMETREL
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	1
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for SYMMETREL
Clinical Trial Phase	Trials
Completed	7
Terminated	3
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SYMMETREL

Sponsor Name

Chart
Table

Sponsor Name for SYMMETREL
Sponsor	Trials
U.S. Department of Education	2
Atrium Health	2
Carolinas Healthcare System	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for SYMMETREL
Sponsor	Trials
Other	23
U.S. Fed	3
Industry	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.